The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.

MLA

Klontz, Karl C., et al. “The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.” Public Health Reports (Washington, D.C. : 1974), vol. 130, no. 5, Sept. 2015, pp. 526–32. EBSCOhost, https://doi.org/10.1177/003335491513000515.

APA

Klontz, K. C., DeBeck, H. J., LeBlanc, P., Mogen, K. M., Wolpert, B. J., Sabo, J. L., Salter, M., Seelman, S. L., Lance, S. E., Monahan, C., Steigman, D. S., & Gensheimer, K. (2015). The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement. Public Health Reports (Washington, D.C. : 1974), 130(5), 526–532. https://doi.org/10.1177/003335491513000515

Chicago

Klontz, Karl C, Heidi J DeBeck, Pamela LeBlanc, Kathryn M Mogen, Beverly J Wolpert, Jonathan L Sabo, Monique Salter, et al. 2015. “The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.” Public Health Reports (Washington, D.C. : 1974) 130 (5): 526–32. doi:10.1177/003335491513000515.